Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

3-Chloro-6-[4-(2-pyrid-yl)piperazin-1-yl]pyridazine.

ABSTRACT: In the title compound, C(13)H(14)ClN(5), the piperazine ring adopts a chair conformation and the dihedral angle between the aromatic rings is 13.91?(7)°. The crystal structure is stabilized by weak inter-molecular C-H?N hydrogen-bond inter-actions.

SUBMITTER: Arslan H

PROVIDER: S-EPMC2980189 | biostudies-literature | 2009 Dec

REPOSITORIES: biostudies-literature

ACCESS DATA

Json Xml

Publications

3-Chloro-6-[4-(2-pyrid-yl)piperazin-1-yl]pyridazine.

Arslan Hakan H Utku Semra S Hardcastle Kenneth I KI Gökçe Mehtap M Lense Sheri S

Acta crystallographica. Section E, Structure reports online 20091204 Pt 1

In the title compound, C(13)H(14)ClN(5), the piperazine ring adopts a chair conformation and the dihedral angle between the aromatic rings is 13.91 (7)°. The crystal structure is stabilized by weak inter-molecular C-H⋯N hydrogen-bond inter-actions. ...[more]

PMID: 21580140

Similar Datasets

3-Chloro-6-{4-[3-(4-chloro-phen-oxy)prop-yl]piperazin-1-yl}pyridazine.

Project description:In the title compound, C(17)H(20)Cl(2)N(4)O, the piperazine ring adopts a chair conformation and the dihedral angle between the pyridazine ring and the benzene ring is 36.3 (1)°. In the crystal, weak C-H⋯O and C-H⋯(N,N) inter-actions help to establish the packing, which also features short inter-molecular Cl⋯Cl contacts [3.331 (2) Å].

| S-EPMC2983611 | biostudies-literature

3-Chloro-6-{4-[3-(trifluoro-meth-yl)phen-yl]piperazin-1-yl}pyridazine.

Project description:The title compound, C(15)H(14)ClF(3)N(4), was synthesized from 3,6-dichloro-pyridazine and 1-[3-(trifluoro-meth-yl)phen-yl]piper-azine. The piperazine ring is flanked by 3-chloro-pyridazine and 3-trifluoro-methyl-phenyl rings and adopts a chair conformation, whereas the 3-chloro-pyridazine and 3-trifluoro-methyl-phenyl rings are planar, with maximum deviations of 0.0069?(13) and 0.0133?(14)?Å, respectively. The crystal structure is stabilized by weak inter-molecular C-H?N hydrogen-bond inter-actions.

| S-EPMC2983628 | biostudies-literature

3-Chloro-6-(1H-pyrazol-1-yl)pyridazine.

Project description:The title compound, C(7)H(5)ClN(4), is almost planar (r.m.s. deviation = 0.022?Å). The dihedral angle between the aromatic rings is 2.82?(5)°. The packing results in polymeric chains extending along the a axis. In the crystal, mol-ecules are connected to each other through inter-molecular C-H?N hydrogen bonds, resulting in R(2) (2)(10) ring motifs.

| S-EPMC3007276 | biostudies-literature

7-Chloro-4-(piperazin-1-yl)quinoline.

Project description:There are two mol-ecules in the asymmetric unit (Z' = 2) of the title compound, C(13)H(14)ClN(3), Each mol-ecule is linked by N-H⋯N hydrogen bonds to another of the same type in a chain in [110]. The crystal studied was a non-merohedral twin with components 0.622 (2) and 0.378 (2).

| S-EPMC3344606 | biostudies-literature

3-Chloro-6-[2-(propan-2-yl-idene)hydrazin-yl]pyridazine.

Project description:In the title compound, C(7)H(9)ClN(4), the 3-chloro-6-hydrazinylpyridazine unit is planar (r.m.s. deviation = 0.0219?Å) and is oriented at a dihedral angle 4.66?(27)° with respect to the propan-2-yl-idene group. In the crystal, the mol-ecules are linked into non-planar dimers due to a crystallographic twofold rotation via N-H?N hydrogen bonds with R(2) (2)(8) graph-set ring motifs.

| S-EPMC3008033 | biostudies-literature

4-Chloro-N-(2-pyrid-yl)aniline.

Project description:There are two mol-ecules in the asymmetric unit of the title compound, C(11)H(9)ClN(2), with dihedral angles of 41.84 (12) and 49.24 (12)° between the aromatic ring planes. The two mol-ecules form a dimer via a pair of N-H⋯N hydrogen bonds.

| S-EPMC2959926 | biostudies-literature

4-(4-Pyrid-yl)pyridinium penta-aqua(pyridazine-4,5-dicarboxyl-ato)praseodymate(III).

Project description:In the title complex, (C(10)H(9)N(2))[Pr(C(6)H(2)N(2)O(4))(2)(H(2)O)(5)], the Pr atom is nine-coordinated by nine O atoms from two pyridazine-4,5-dicarboxyl-ate anions and five water mol-ecules. It is noteworthy that there is a protonated bipyridine mol-ecule in the structure. Inter-molecular O-H?O, O-H?N and N-H?N hydrogen bonds are present, resulting in a three-dimensional network.

| S-EPMC2983157 | biostudies-literature

3-Chloro-6-(3,5-dimethyl-1H-pyrazol-1-yl)pyridazine.

Project description:In the title compound, C(9)H(9)ClN(4), the dihedral angle between the aromatic rings is 6.25?(9)°. The whole mol-ecule is approximately planar (r.m.s. deviation = 0.070?Å). In the crystal, ?-? inter-actions between the centroids of the pyridazine rings [separation = 3.5904?(10)?Å] occur.

| S-EPMC2983344 | biostudies-literature

Hexachloridobis-{?-2-(piperazin-1-yl)-N-[1-(2-pyrid-yl)ethyl-idene]ethanamine}-trizinc dihydrate.

Project description:In the trinuclear title compound, [Zn(3)Cl(6)(C(13)H(20)N(4))(2)]·2H(2)O, each terminal Zn(II) atom is coordinated by an N(3) donor set from the Schiff base ligands and two Cl atoms in a distorted square-pyramidal geometry. The central Zn(II) atom is tetra-hedrally coordinated by two piperazine N atoms from two Schiff base ligands and two Cl atoms. The piperazine rings adopt chair conformations. In the crystal structure, adjacent complex mol-ecules are linked into a three-dimensional network via N-H?O, C-H?Cl and C-H?O hydrogen bonds. The structure includes two water mol-ecules, one of which is disordered over two positions with occupancies of 0.753?(15) and 0.247?(15).

| S-EPMC3212165 | biostudies-literature

1-Chloro-2-(4-phenyl-piperazin-1-yl)ethanone.

Project description:The title compound, C(12)H(15)ClN(2)O, is a piperazine derivative with the potential for use as a starting material for pharmaceutial and agrochemical applications. The structure is stabilized by C-H⋯O hydrogen bonds, C-H⋯π inter-actions and π-π stacking inter-actions [centroid-centroid distance = is 4.760 (2) Å].

| S-EPMC2969821 | biostudies-literature

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data